Form 4: AtriCure Director Karen Prange Reports Acquisition of Shares Through Restricted Stock Award

Director Karen Prange reports acquiring 5,401 shares of AtriCure, Inc. through a restricted stock award that vests in one year.

Summary

• Karen Prange, a director of AtriCure, Inc., filed a Form 4 to report changes in beneficial ownership.
• On May 19, 2025, Prange acquired 5,401 shares of AtriCure common stock through a restricted stock award under the company's 2023 Stock Incentive Plan.
• The shares were acquired at a price of $0.
• These shares will vest on the one-year anniversary of the grant date.
• Following the transaction, Prange beneficially owns 23,229 shares of AtriCure common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of a stock award, which doesn't inherently indicate positive or negative sentiment, but the acquisition of shares by a director is generally viewed as a positive sign.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The restricted stock award vests in one year, suggesting a commitment to the company's long-term performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the ownership changes of company insiders.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates

Keywords

AtriCure, Director, Karen Prange, Form 4, Beneficial Ownership, Restricted Stock Award, Stock Incentive Plan, ATRC